Corona-Impfstoff: Sanofi und GlaxoSmithKline mit Milliarden-Deal in USA – Aktien profitieren

Die Pharmakonzerne Sanofi und GlaxoSmithKline haben mit der US-Regierung einem Milliardendeal zur Weiterentwicklung eines potenziellen Corona-Impfstoffs erhalten.
(Orginal – Story lesen…)

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
690